Coronary Artery Disease, Ischemia and No Obstructive Coronary Arteries, Ischemic Heart Disease, Microvascular Angina, Vasospastic Angina
Conditions
Keywords
coronary artery disease, ischemia and no obstructive coronary arteries, ischemic heart disease, microvascular angina, vasospastic angina, coronary microvascular dysfunction, coronary microcirculation, endothelial dysfunction
Brief summary
Patients with chronic coronary syndromes (CCS) diagnosed without significant lesions in invasive coronary angiography (ischemia non-obstructive coronary artery disease - INOCA) represent approximately 50% of all patients with CCS. Results of FAME study clearly showed that evaluation of coronary circulation should not be accomplished only with visual assessment in resting conditions. Current European Society of Cardiology Guidelines of diagnosis and treatment of CCS published in 2019 emphasize the necessity of performing complex coronary physiology assessment. Invasive physiological measurements and vasoreactivity provocative tests emerged as key tools to differentiate between vasospastic angina, microcirculatory angina, overlap of both conditions or non-cardiac disease. According to contemporary literature, identification of heterogeneity of patients with INOCA is crucial for determination of adequate treatment. An appropriate pharmacotherapy has a potential to improve outcomes including grade of angina, quality of life, exertional tolerance and most important - MACCE (major adverse cardiac and cardiovascular events) free survival. However, there is a lack of evidence on each of the subtypes of INOCA especially in those with signs and symptoms of vasospasm in provocative test but without visual spasm in epicardial vessels.
Interventions
DIAGNOSTIC_TESTComprehensive functional diagnostics of coronary circulation
Comprehensive functional diagnostics of coronary circulation in patients with INOCA (ischemia and no obstructive coronary arteries) including: * echocardiography with assessment of diastolic function * flow-mediated dilation of brachial artery * coronary angiography * functional coronary assessment (RFR, FFR, IMR, CFR, dp/dt, Tau) * provocative test with acetylcholine (registration of symptoms, ECG and angiographic spasm) * laboratory tests (full blood count, serum creatinine level, eGFR, lipidogram, serum CRP/hsCRP level, serum NT-proBNP level) * serum level of inflammatory cytokines and chemokines
Sponsors
Abbott
Bartlomiej Guzik
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Inclusion criteria
1. Diagnosed chronic coronary syndrome CCS ≥ 2. 2. Evidence of myocardial ischemia (positive result of non-invasive stress test). 3. Informed consent. 4. Age at least 18 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diastolic Disfunction parameters in ECHO | baseline, 12- and 24-month follow-up |
| Cytokines (serum levels) | baseline |
Secondary
| Measure | Time frame |
|---|---|
| MACCE occurrence | baseline, 12- and 24-month observation |
| Hospitalization any | baseline, 12- and 24-month observation |
| symptoms intensity and quality of life (questionnaires) | baseline, 12- and 24-month observation |
| FMD | baseline, 12- and 24-month observation |
Countries
Poland
Contacts
Primary ContactBartłomiej Guzik, MD, PhD
Backup ContactPiotr Szolc, MD
Outcome results
None listed